

[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
Sarah James Initiated (TDOC) at Buy and Held Target at $22 on, Feb 29th, 2024
Sarah James of Cantor Fitzgerald, Initiated "Teladoc Health, Inc." (TDOC) at Buy and Held Target at $22 on, Feb 29th, 2024.
Sarah has made no other calls on TDOC in the last 4 months.
There are 8 other peers that have a rating on TDOC. Out of the 8 peers that are also analyzing TDOC, 4 agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Cherny of "Leerink Partners" Initiated at Hold and Held Target at $17 on, Monday, February 26th, 2024
- Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $19 on, Wednesday, February 21st, 2024
- Gil Luria of "DA Davidson" Maintained at Hold with Decreased Target to $18 on, Wednesday, February 21st, 2024
- Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $19 on, Friday, November 17th, 2023
These are the ratings of the 4 analyists that currently disagree with Sarah
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $28 on, Wednesday, February 21st, 2024
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
Contributing Sources